Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease

Publisher： Karger

E-ISSN： 1421-9670|45|2|149-159

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.45, Iss.2, 2016-12, pp. : 149-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease Patients

By  

Cardiorenal Medicine, Vol. 6, Iss. 1, 2015-0 ,pp. : 73-82

Karger

Access to resources Recommend Favorite

Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 146-148

Karger

Access to resources Recommend Favorite

Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes

By  

American Journal of Nephrology, Vol. 46, Iss. 3, 2017-09 ,pp. : 213-221

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 and Matrix-Metalloproteinases in Patients with Chronic Kidney Disease: Are They Associated with Cardiovascular Disease?

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 4, 2009-10 ,pp. : 276-283

Karger

Access to resources Recommend Favorite

Calcification of the Aortic Arch Predicts Cardiovascular and All-Cause Mortality in Chronic Hemodialysis Patients

By  

Cardiorenal Medicine, Vol. 4, Iss. 1, 2014-03 ,pp. : 34-42

Karger

Access to resources Recommend Favorite